Explore the Demand for Immunoassay CDMO in Japan — analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036

Future Market Insights

Demand for Immunoassay CDMO in Japan

Key Insight

Immunoassay CDMO demand in Japan is projected to grow from USD 0.50 billion in 2025 to USD 1.02 billion by 2036, at a CAGR of 6.7%. Manufacturing and Production will dominate with a 53.0% services share, while Diagnostic Companies will dominate with a 48.2% end user share.

April 14, 2026

Anurag Sharma

250 Pages

Cite this Report

Demand for Immunoassay CDMO in Japan

https://www.futuremarketinsights.com/reports/japan-immunoassay-cdmo-market

License

Buy Now

Summary ToC Companies

Key Players

Biopharma Group
Firalis Molecular Precision
GTP Bioways©
ProBio
Sanner GmbH

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Demand for Immunoassay CDMO in Japan

Key Players

Similar Industry Reports